Bridgeway Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$13K | – | 1372 |
|
|
2022
Q3 | $13K | Sell |
1,000
-1,250
| -56% | -$16.3K | ﹤0.01% | 1398 |
|
|
2022
Q2 | $33K | Sell |
2,250
-750
| -25% | -$11K | ﹤0.01% | 1302 |
|
|
2022
Q1 | $112K | Sell |
3,000
-750
| -20% | -$28K | ﹤0.01% | 1250 |
|
|
2021
Q4 | $215K | Hold |
3,750
| – | – | ﹤0.01% | 1154 |
|
|
2021
Q3 | $383K | Buy |
+3,750
| New | +$383K | 0.01% | 1110 |
|